Thai Acute Lymphoblastic Leukemia registry

Clinical Characteristics and Treatment Outcomes of Patients with Acute Lymphoblastic Leukemia in Thailand: a Multicenter study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20150518001

Enrollment

150

Registered

2015-05-18

Start date

2015-05-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia Acute lymphoblastic leukemia ALL Thai Adult

Interventions

ALL patients age 15&#45

40 years,ALL patients age more than 40 years

Treatment,Treatment

Adolescent and young adult,ALL patients

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed acute lymphoblastic leukemia

Exclusion criteria

Exclusion criteria: 1. Patients with relapsed acute lymphoblastic leukemia 2. Patients with chronic myeloid leukemia in lymphoid blastic crisis 3. Patients who refuse to participate in the study

Design outcomes

Primary

Measure	Time frame
Overall survival 3 years Kaplan-Meier's survival,Incidence 3 years Proportion base on population	—

Secondary

Measure	Time frame
Clinical characteristics 3 years chi-square, t-test, or Mann-Whitney-U test where appropriate,Comparative survival between each chemotherapy regimen 3 years Kaplan-Meier survival analysis with log-rank test or Cox proportional hazard	—

Countries

Thailand

Contacts

Public ContactWasithep Limvorapitak

Faculty of Medicine, Thammasat University

wasithep@tu.ac.th02-926-9793

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026